PuSH - Publikationsserver des Helmholtz Zentrums München

Lunding, L.P.* ; Weckmann, M.* ; Zissler, U.M. ; Jakwerth, C.A. ; Bodenstein-Sgró, R.* ; Webering, S.* ; Vock, C.* ; Ehlers, J.C.* ; Fernandez Ceballos, R.A.M.* ; Nemani, S.S.P.* ; Reddy, K.D.* ; Oliver, B.G.G.* ; Vermeulen, C.J.* ; van de Berge, M.* ; Ober, C.* ; Künstner, A.* ; Busch, H.* ; König, I.* ; Garbers, C.* ; Schmidt-Weber, C.B. ; Nold, M.F.* ; Yildirim, A.Ö. ; Nold-Petry, C.A.* ; Orinska, Z.* ; Bahmer, T.* ; Heyckendorf, J.* ; Hansen, G.* ; von Mutius, E. ; Rabe, K.F.* ; Dittrich, A.M.* ; Schaub, B. ; Brinkmann, F.* ; Kopp, M.V.* ; Wegmann, M.*

Immune training of the interleukin 6 gene in airway epithelial cells is central to asthma exacerbations.

Allergy, DOI: 10.1111/all.70070 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
QUESTION: Epidemiological studies suggest that respiratory viral infections are major triggers of asthma exacerbations, and clinical studies have suggested the involvement of an increased interleukin-6 (IL-6) release. What is the pathophysiological role of IL-6 in asthma exacerbation, and which mechanisms lead to enhanced IL-6 release? MATERIALS AND METHODS: Exacerbations of ovalbumin-induced experimental allergic asthma were elicited in wild-type and IL-6-deficient mice by intranasal (i.n.) application of poly(I:C). Airway inflammation, cytokine expression and release, mucus production and airway hyperresponsiveness were measured. IL-6 was neutralised by i.n. anti-IL-6 antibody application. The human bronchial epithelial cell line, BEAS-2B, was stimulated with poly(I:C) and infected with human rhinovirus-16 in vitro, followed by quantification of IL6 gene expression and DNA methylation. Genome-wide DNA methylation was assessed in bronchial epithelial cells from adults with asthma (cohort I, n = 54) and in nasal epithelial cells from children and adults in the All-Age-Asthma cohort (ALLIANCE, n = 53 and n = 108 respectively). RESULTS: Poly(I:C)-induced experimental exacerbations in mice were preceded and paralleled by exaggerated IL-6 release in the airway epithelium, with IL-6 neutralisation completely preventing experimental exacerbations. Repetitive infection/stimulation with RV16 or poly(I:C) resulted in training of the IL-6 release in human respiratory epithelial cells. In patients, hypomethylation at the IL6 gene methylation was associated with high IL6 expression and future exacerbations. ANSWER: An exaggerated IL-6 release is required for exacerbation of experimental asthma, potentially the result of viral PAMP-induced immune training of airway epithelial cells. Additionally, patients with asthma carrying the epigenetic signature of a trained IL-6 response exacerbate more frequently. These findings open new avenues to identify and treat exacerbation-prone patients.
Impact Factor
Scopus SNIP
Altmetric
12.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Il‐6 ; Asthma ; Exacerbations ; Immune Training ; Respiratory Viruses; Inflammatory Cytokines; Predictors
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
Institute of Lung Health and Immunity (LHI)
Institute of Asthma and Allergy Prevention (IAP)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
Lung Research
PSP-Element(e) G-505400-001
G-505000-007
G-503300-001
G-501600-001
Förderungen Deutsches Zentrum für Lungenforschung
Scopus ID 105021367370
PubMed ID 41099307
Erfassungsdatum 2025-10-17